ClinicalTrials.gg
CompletedNCT04309864Updated Oct 9, 2026Results posted

CMAP Refinement for Pressure Injury Prevention

An interventional study of Use of CMAP app for education (in-hospital) and Use of CMAP app (in-home) in Pressure Ulcer, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Prevention

How we know

Updated Oct 9, 2026Results postedStudy documents posted+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
43
Allocation
Non-randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 153 studies in Pressure Ulcer with a site in United States — 25 open to participants now, 28 under way, none of them phase 3. Pressure Ulcer · United States.

Enrollment
63rd of 118
43 · median 48
Started
2020
with 4 others
No phase
88 of 153
10 open now
Registered
104th of 153
by date

Among the 153 studies in Pressure Ulcer with a site in United States, this one is the 63rd largest by enrollment of the 118 interventional ones that give a count, is one of 5 that started in 2020, is one of 88 with no phase, and was the 104th registered.

Pressure Ulcer

548 studies on the registry are indexed under Pressure Ulcer; 127 are open to participants now.

Browse Pressure Ulcer studies →

Open to participants now

25 of the 153 studies in Pressure Ulcer with a site in United States are open now. Recruiting first, the newest first:

20 more — sign in →

All 25 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 61 Pressure Ulcer studies recruiting now, 45 (74%) set no upper age limit and 6 (10%) stop at 75 or younger; 10 take children under 18; 13 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 153 studies in Pressure Ulcer with a site in United States, or all of them as a file.
02

Study summary

For Veterans with spinal cord injury who use a wheelchair, pressure injuries related to sitting are a significant daily threat to well-being. Pressure injuries are costly to treat, negatively impact quality of life and community participation, and can be life threatening. Moving or shifting at regular intervals in the wheelchair redistributes harmful pressure and reduces risk for skin breakdown, yet these movements are a challenge to perform consistently. The challenge exists due to lack of sensation to let the individual know they need to shift their weight. Pressure mapping provides a detailed visual representation of pressure distribution and can compensate for impaired sensation. Pressure mapping feedback delivered on-demand on mobile platforms can potentially increase effectiveness in carrying out behaviors to reduce risk for pressure injury when used during clinician-delivered education to set goals and monitor progress and when used at home as a self-management strategy.

Read the detailed description

Objectives: The long-term goal of this project is to improve the effectiveness of pressure injury prevention education by clinicians and self-management by Veterans with spinal cord injury (SCI) through a methodical development and testing of a mobile platform based pressure mapping system called "Comprehensive Mobile Assessment of Pressure" (CMAP). The targeted risk-reduction behavior in this project is the effective use of weight shifts when sitting in a wheelchair by improving consistency, frequency, duration, and quality of movements to redistribute pressure. CMAP provides visual cues as well as individually customizable reminders that are designed to compensate for the lack of sensation that prevents the use of natural cues to redistribute pressure, by wheelchair users. An updated CMAP system will serve two important objectives: 1) assist clinicians in assessment, individualized goal-setting, and monitoring the Veteran with SCI's progress toward pressure injury prevention behavior goals while in the hospital setting; and 2) assist clinicians with individualized setup and education of the Veteran with SCI for using the CMAP system in the home setting as a self-management strategy for pressure injury prevention.

Specific Aims: The specific aims of this study include: 1a) hardware expansion to improve functionality of the CMAP system to add a docking and charging station and use of CMAP on a smartwatch based on Veteran preferences and 1b) software expansion to enhance clinical education for pressure injury prevention education, with requirements provided by clinicians; 2) determine usability of the refined CMAP system when it is integrated into patient education for Veteran's with acute SCI during their inpatient rehabilitation stay, and 3) a determine usability and efficacy of the refined CMAP system for clinician-delivered pressure injury prevention education, followed by Veteran use of CMAP in their daily routines at home.

Study Design: This four-year study will have multiple stages and will use a mixed methods approach that includes iterative focus groups and interviews with Veterans who have SCI and with clinicians who provide pressure injury prevention education to Veterans with SCI; self-efficacy and usability surveys for both Veterans and clinicians; pilot testing of CMAP during inpatient rehabilitation and testing during outpatient visits. Repeated measures will be used to evaluate changes within subject for completion of weight shifts while using CMAP, compared to periods when not using CMAP.

Methods: During the first two years, improvements to CMAP hardware and software will be guided by experience-based design guided requirements learned about through iterative focus groups including Veterans with SCI/D (n=10) and clinicians (n=10). Usability will be measured at each iteration of development using the System Usability Scale (SUS) and the User Experience Questionnaire (UEQ). The focus groups will be repeated to ensure alignment between development progress and the requirements identified by the focus groups. During the inpatient pilot test, clinician (n=3) and Veteran (n=6) self-efficacy will be measured. Veterans will complete selected sub-scales from the Skin Care Belief Scale and clinicians will answer survey questions developed specifically around providing education for performing weight shifts effectively. Veteran progress toward weight shift goals will be measured through performance monitoring within the CMAP app; Actual performance will be assessed against the individualized goals set by the clinician. During the outpatient testing, Veterans (n=20) will use CMAP at home for 2 weeks after receiving education and individualized goals for weight shift performance by clinicians. While at home, trunk movements will be monitored via actigraphy to monitor weight shift frequency to compare to baseline trunk movement data, weight shift performance data within CMAP app, and finally, compared with individualized goals for performing weight shifts. Self efficacy and usability (SUS and UEQ) of the overall system in both settings will be measured.

03

Conditions studied

  • Pressure Ulcer

Keywords

  • skin ulcer
  • wounds and injuries
  • decubitus ulcer
  • wheel chairs
  • spinal cord injury
  • seating
  • pressure injury prevention
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For Aim 1a:

  • Veteran adults aged 18-80
  • male and female
  • with a spinal cord injury (C4 and below) or spinal cord disorder with impaired sensory function and a wheelchair user for at least one year

For Aim 2: Veteran adults aged 18-80, male and female, with a recent spinal cord injury (C4 and below) or a spinal cord disorder with impaired sensory function, who are currently in inpatient rehabilitation with at least 1 week prior to discharge. Participants must demonstrate ability to access the CMAP system application on a mobile phone or tablet independently.

For Aim 3:

  • Veteran adults aged 18-80
  • male and female
  • manual or power wheelchair users
  • at least one year post SCI onset
  • (C4 and below) or a spinal cord disorder with impaired sensory function
  • who are visiting the MVAHCS SCI/D Center for their annual visit or at end of a non-pressure injury stay in the hospital
  • at which time review of pressure injury prevention and assessment of wheelchair seating are routinely conducted by clinicians
  • Veterans using the CMAP system must demonstrate ability to access the CMAP app on a mobile phone or tablet independently

Clinicians inclusion Criteria for Aim 1b; Aims 2 and 3:

  • Clinicians (SCI/D Physical and Occupational Therapists and Nurses and Ancillary Clinician) who, in their normal scope of work, provide patient education for pressure injury prevention

Exclusion criteria

Exclusion Criteria:

For Aim 1a:

  • Any Veteran with SCI/D who is unable to verbally and cognitively communicate with the study team

For Aims 2, and 3:

  • Any Veteran with SCI/D who has an active pressure injury that contacts their seating system or within six months of a flap surgery
  • Any Veteran with SCI/D who is unable to verbally and cognitively communicate with the study team
  • Any Veteran whose seat cushion is a customized immersion style
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
43 participants (actual)

Study arms

  • No intervention
    Aim 1 Veteran Focus Group 1

    Veterans will inform study staff regarding desired device design refinements over three focus groups. Outcome measures are collected for Focus Groups 1 and 3.

  • No intervention
    Aim 1 Clinician Focus Group 1

    Clinicians will inform study staff regarding desired app design changes over three focus groups. Outcome measures are collected for Focus Groups 1 and 3.

  • Other
    Aim 2 Veterans

    Clinicians will use the updated CMAP system during patient education for prevention of pressure injuries with Veterans with SCI who are completing their initial rehabilitation.

    Device: Use of CMAP app for education (in-hospital)

  • Other
    Aim 3 Veterans

    The Veteran will use the CMAP system at home for two weeks to use in their daily routines, along with wearing the acti-graph one week prior, two weeks during and one week after CMAP usage.

    Device: Use of CMAP app (in-home)

  • Other
    Aim 2 Clinicians

    Clinicians will use the updated CMAP system during patient education for prevention of pressure injuries with Veterans with SCI who are completing their initial rehabilitation.

    Device: Use of CMAP app for education (in-hospital)

  • Other
    Aim 3 Clinicians

    The Veteran will use the CMAP system at home for two weeks to use in their daily routines, along with wearing the acti-graph one week prior, two weeks during and one week after CMAP usage.

    Device: Use of CMAP app (in-home)

  • No intervention
    Aim 1 Clinician Focus Group 3

    Clinicians will inform study staff regarding desired app design changes over three focus groups. Outcome measures are collected for Focus Groups 1 and 3.

  • No intervention
    Aim 1 Veteran Focus Group 3

    Veterans will inform study staff regarding desired device design refinements over three focus groups. Outcome measures are collected for Focus Groups 1 and 3.

Interventions

  • DeviceUse of CMAP app for education (in-hospital)

    Clinicians will use the updated CMAP system during patient education for prevention of pressure injuries with Veterans with SCI who are completing their initial rehabilitation.

  • DeviceUse of CMAP app (in-home)

    The Veteran will use the CMAP system at home for two weeks during their daily routines.

06

What researchers measure

Primary outcomes

  1. Change in Usability as Measured by System Usability Scale (SUS)

    The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (Veterans) to give their subjective assessment of the Smart watch as part of the CMAP system. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.

    Time frame: Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)

  2. Usability as Measured by User Experience Questionnaire (UEQ)

    The User Experience Questionnaire (UEQ) is a 26 item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participant's (Veterans) impression of the of their experience with the Smart watch as part of the CMAP system. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.

    Time frame: Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)

  3. Change in Usability as Measured by System Usability Scale (SUS)

    The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (clinicians) to give their subjective assessment of the newly developed educational formats in the CMAP system. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.

    Time frame: Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)

  4. Change in Usability as Measured by User Experience Questionnaire (UEQ)

    The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (clinicians) impression of the of their experience with the newly developed educational formats of the CMAP system. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.

    Time frame: Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)

  5. Change in Usability as Measured by System Usability Scale (SUS)

    The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (Veterans) to give their subjective assessment of the CMAP system after using it during their acute rehabilitation. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model

    Time frame: Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment)

  6. Change in Usability as Measured by User Experience Questionnaire (UEQ)

    The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (Veterans) impression of the of their experience with the CMAP system after using it during Veterans' during their acute rehabilitation. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.

    Time frame: Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment)

  7. Change in Usability as Measured by System Usability Scale (SUS)

    The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (clinicians) to give their subjective assessment of the educational formats in the CMAP system after using it for Veterans' acute rehabilitation. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model

    Time frame: Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment for each Veteran case)

  8. Change in Usability as Measured by User Experience Questionnaire (UEQ)

    The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (clinicians) impression of the of their experience with the CMAP educational formats after using it for Veterans' acute rehabilitation. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.

    Time frame: Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment for each Veteran case)

  9. Change in Usability as Measured by System Usability Scale (SUS)

    The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (Veterans) to give their subjective assessment of the CMAP system after using it in the outpatient and community-based settings. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.

    Time frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)

  10. Change in Usability as Measured by User Experience Questionnaire (UEQ)

    The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (Veterans) impression of the of their experience with the CMAP system at the start of intervention and after using the CMAP system in the outpatient and community-based settings. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.

    Time frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)

  11. Change in Usability as Measured by System Usability Scale (SUS)

    The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (clinicians) to give their subjective assessment of the educational formats in the CMAP system after using it for Veterans' in the outpatient and community-based settings. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.

    Time frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)

  12. Change in Usability as Measured by User Experience Questionnaire (UEQ)

    The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (clinicians) impression of the of their experience with the CMAP educational formats at the start of intervention and after using the CMAP system in the outpatient and community-based settings. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.

    Time frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)

Secondary outcomes

  1. Pressure Ulcer Knowledge Test

    The Pressure Ulcer Knowledge Test is a 9-item multiple choice survey intended to assess individuals' knowledge of pressure injury prevention activities and treatments. Total score is reported, with range 9-27. Higher scores indicate better understanding of pressure injury prevention practices.

    Time frame: Change from Aim 2 baseline (time of enrollment) to end of Aim 2 intervention (10 days following enrollment)

  2. Therapist Self-Efficacy for Weight Shifts to Prevent Pressure Injuries

    This self-efficacy measures clinician confidence in delivering pressure injury prevention education, specifically around instruction of how to perform weight shifts using the CMAP system during Veterans' acute rehabilitation. Total scores are reported, with range 4-40. Higher scores indicate better self-efficacy.

    Time frame: Change from Aim 2 baseline (time of enrollment) to end of Aim 2 intervention (10 days following enrollment for each Veteran case)

  3. Pressure Ulcer Knowledge Test

    The Pressure Ulcer Knowledge Test is a 9-item multiple choice survey intended to assess individuals' knowledge of pressure injury prevention activities and treatments. Total score is reported, with range 9-27. Higher scores indicate better understanding of pressure injury prevention practices.

    Time frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)

  4. Therapist Self-Efficacy for Weight Shifts to Prevent Pressure Injuries

    This self-efficacy measures clinician confidence in delivering pressure injury prevention education, specifically around instruction of how to perform weight shifts using the CMAP system during Veterans' acute rehabilitation. Total scores are reported, with range 4-40. Higher scores indicate better self-efficacy.

    Time frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)

07

Results

Posted Oct 9, 2026

Participant flow

Participant flow — Overall Study
MilestoneAim 1 Veteran Focus Group 1Aim 1 Clinician Focus Group 1Aim 1 Veteran Focus Group 3Aim 1 Clinician Focus Group 3Aim 2 Veterans (In-Hospital CMAP App)Aim 2 Clinicians (In-Hospital CMAP App)Aim 3 Veterans (In-Home CMAP App)Aim 3 Clinicians (In-Home CMAP App)
Started76755562
Completed76755562
Not completed00000000

Outcome measures

PrimaryChange in Usability as Measured by System Usability Scale (SUS)

The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (Veterans) to give their subjective assessment of the Smart watch as part of the CMAP system. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.

Time frame:
Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
Reported as:
Mean · score on a scale
Change in Usability as Measured by System Usability Scale (SUS)
score on a scaleAim 1 Veteran Focus Group 1Aim 1 Veteran Focus Group 3
Change in Usability as Measured by System Usability Scale (SUS)80.4167 ± 15.605882.50 ± 8.6603
Statistical analysis
  • Aim 1 Veteran Focus Group 1 vs Aim 1 Veteran Focus Group 3 · Wald test for medians · p = 0.8122
PrimaryUsability as Measured by User Experience Questionnaire (UEQ)

The User Experience Questionnaire (UEQ) is a 26 item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participant's (Veterans) impression of the of their experience with the Smart watch as part of the CMAP system. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.

Time frame:
Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
Reported as:
Mean · score on a scale
Usability as Measured by User Experience Questionnaire (UEQ)
score on a scaleAim 1 Veteran Focus Group 1Aim 1 Veteran Focus Group 3
UEQ Attractiveness2.4183 ± 0.95361.78 ± 0.9753
UEQ Perspicuity2.5833 ± 0.43781.75 ± 1.00
UEQ Efficiency1.875 ± 1.03381.9167 ± 0.8036
UEQ Dependability2.4583 ± 0.53421.8333 ± 1.0104
UEQ Stimulation2.2083 ± 1.1772.25 ± 0.75
UEQ Novelty2.0833 ± 1.31021.8333 ± 1.2583
Statistical analysis
  • Aim 1 Veteran Focus Group 1 vs Aim 1 Veteran Focus Group 3 · Wald test for medians · p = 0.5732
  • Aim 1 Veteran Focus Group 1 vs Aim 1 Veteran Focus Group 3 · Wald test for medians · p = 0.3006
  • Aim 1 Veteran Focus Group 1 vs Aim 1 Veteran Focus Group 3 · Wald test for medians · p = 1.00
  • Aim 1 Veteran Focus Group 1 vs Aim 1 Veteran Focus Group 3 · Wald test for medians · p = 0.6089
  • Aim 1 Veteran Focus Group 1 vs Aim 1 Veteran Focus Group 3 · Wald test for medians · p = 0.593
  • Aim 1 Veteran Focus Group 1 vs Aim 1 Veteran Focus Group 3 · Wald test for medians · p = 0.6843
PrimaryChange in Usability as Measured by System Usability Scale (SUS)

The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (clinicians) to give their subjective assessment of the newly developed educational formats in the CMAP system. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.

Time frame:
Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
Reported as:
Mean · score on a scale
Change in Usability as Measured by System Usability Scale (SUS)
score on a scaleAim 1 Clinician Focus Group 1Aim 1 Clinician Focus Group 3
Change in Usability as Measured by System Usability Scale (SUS)71.67 ± 6.8379.00 ± 7.2
Statistical analysis
  • Aim 1 Clinician Focus Group 1 vs Aim 1 Clinician Focus Group 3 · Wald test for medians · p = 0.1176
PrimaryChange in Usability as Measured by User Experience Questionnaire (UEQ)

The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (clinicians) impression of the of their experience with the newly developed educational formats of the CMAP system. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.

Time frame:
Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
Reported as:
Mean · score on a scale
Change in Usability as Measured by User Experience Questionnaire (UEQ)
score on a scaleAim 1 Clinician Focus Group 1Aim 1 Clinician Focus Group 3
UEQ Attractiveness1.75 ± 0.462.4 ± 0.38
UEQ Perspicuity1.21 ± 1.81.8 ± 0.54
UEQ Efficiency1.63 ± 0.382.3 ± 0.48
UEQ Dependability1.54 ± 0.492.15 ± 0.55
UEQ Stimulation2.25 ± 0.272.7 ± 0.33
UEQ Novelty2.00 ± 0.762.85 ± 0.14
Statistical analysis
  • Aim 1 Clinician Focus Group 1 vs Aim 1 Clinician Focus Group 3 · t-test, 2 sided · p = 0.0327
  • Aim 1 Clinician Focus Group 1 vs Aim 1 Clinician Focus Group 3 · t-test, 2 sided · p = 0.0458
  • Aim 1 Clinician Focus Group 1 vs Aim 1 Clinician Focus Group 3 · t-test, 2 sided · p = 0.0283
  • Aim 1 Clinician Focus Group 1 vs Aim 1 Clinician Focus Group 3 · t-test, 2 sided · p = 0.0823
  • Aim 1 Clinician Focus Group 1 vs Aim 1 Clinician Focus Group 3 · t-test, 2 sided · p = 0.0343
  • Aim 1 Clinician Focus Group 1 vs Aim 1 Clinician Focus Group 3 · t-test, 2 sided · p = 0.0399
PrimaryChange in Usability as Measured by System Usability Scale (SUS)

The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (Veterans) to give their subjective assessment of the CMAP system after using it during their acute rehabilitation. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model

Time frame:
Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment)
Reported as:
Mean · score on a scale
Change in Usability as Measured by System Usability Scale (SUS)
score on a scaleAim 1 Veteran Focus Group 3Aim 2 Veterans
Change in Usability as Measured by System Usability Scale (SUS)82.5 ± 8.660383.00 ± 13.0384
Statistical analysis
  • Aim 1 Veteran Focus Group 3 vs Aim 2 Veterans · Wald test for medians · p = 0.4697
PrimaryChange in Usability as Measured by User Experience Questionnaire (UEQ)

The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (Veterans) impression of the of their experience with the CMAP system after using it during Veterans' during their acute rehabilitation. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.

Time frame:
Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment)
Reported as:
Mean · score on a scale
Change in Usability as Measured by User Experience Questionnaire (UEQ)
score on a scaleAim 1 Veteran Focus Group 3Aim 2 Veterans
UEQ Attractiveness1.78 ± 0.97531.7333 ± 0.5963
UEQ Perspicuity1.75 ± 1.02.05 ± 0.9253
UEQ Efficiency1.9167 ± 0.80361.8 ± 0.8551
UEQ Dependability1.8333 ± 1.01041.35 ± 1.3062
UEQ Stimulation2.25 ± 1.41.4 ± 1.245
UEQ Novelty1.8333 ± 0.950.95 ± 1.4076
Statistical analysis
  • Aim 1 Veteran Focus Group 3 vs Aim 2 Veterans · Wald test for medians · p = 0.6186
  • Aim 1 Veteran Focus Group 3 vs Aim 2 Veterans · Wald test for medians · p = 0.6812
  • Aim 1 Veteran Focus Group 3 vs Aim 2 Veterans · Wald test for medians · p = 0.4113
  • Aim 1 Veteran Focus Group 3 vs Aim 2 Veterans · Wald test for medians · p = 0.8447
  • Aim 1 Veteran Focus Group 3 vs Aim 2 Veterans · Wald test for medians · p = 0.4113
  • Aim 1 Veteran Focus Group 3 vs Aim 2 Veterans · Wald test for medians · p = 0.4465
PrimaryChange in Usability as Measured by System Usability Scale (SUS)

The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (clinicians) to give their subjective assessment of the educational formats in the CMAP system after using it for Veterans' acute rehabilitation. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model

Time frame:
Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment for each Veteran case)
Reported as:
Mean · score on a scale
Change in Usability as Measured by System Usability Scale (SUS)
score on a scaleAim 1 Clinician Focus Group 3Aim 2 Clinicians
Change in Usability as Measured by System Usability Scale (SUS)82.5 ± 8.660369.5 ± 5.1235
Statistical analysis
  • Aim 1 Clinician Focus Group 3 vs Aim 2 Clinicians · Wald test for medians · p = 0.3826
PrimaryChange in Usability as Measured by User Experience Questionnaire (UEQ)

The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (clinicians) impression of the of their experience with the CMAP educational formats after using it for Veterans' acute rehabilitation. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.

Time frame:
Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment for each Veteran case)
Reported as:
Mean · score on a scale
Change in Usability as Measured by User Experience Questionnaire (UEQ)
score on a scaleAim 1 Clinician Focus Group 3Aim 2 Clinicians
UEQ Attractiveness1.78 ± 0.97531.3667 ± 0.7397
UEQ Perspicuity1.75 ± 1.001.2 ± 0.542
UEQ Efficiency1.9167 ± 0.80361.35 ± 0.6982
UEQ Dependability1.8333 ± 1.01041.25 ± 0.75
UEQ Stimulation2.25 ± 0.752.00 ± 0.8478
UEQ Novelty1.8333 ± 1.25832.05 ± 0.7159
Statistical analysis
  • Aim 1 Clinician Focus Group 3 vs Aim 2 Clinicians · Wald test for medians · p = 0.2592
  • Aim 1 Clinician Focus Group 3 vs Aim 2 Clinicians · Wald test for medians · p = 0.483
  • Aim 1 Clinician Focus Group 3 vs Aim 2 Clinicians · Wald test for medians · p = 0.1988
  • Aim 1 Clinician Focus Group 3 vs Aim 2 Clinicians · Wald test for medians · p = 0.4113
  • Aim 1 Clinician Focus Group 3 vs Aim 2 Clinicians · Wald test for medians · p = 0.8096
  • Aim 1 Clinician Focus Group 3 vs Aim 2 Clinicians · Wald test for medians · p = 1.00
PrimaryChange in Usability as Measured by System Usability Scale (SUS)

The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (Veterans) to give their subjective assessment of the CMAP system after using it in the outpatient and community-based settings. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.

Time frame:
Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)
Reported as:
Mean · score on a scale
Change in Usability as Measured by System Usability Scale (SUS)
score on a scaleAim 3 Veterans (In-Home CMAP App)
Aim 3 Baseline76.25 ± 14.7267
End of Aim 3 Participation85.8333 ± 9.1742
Statistical analysis
  • Aim 3 Veterans (In-Home CMAP App) · Wald test for medians · p = 0.7514
PrimaryChange in Usability as Measured by User Experience Questionnaire (UEQ)

The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (Veterans) impression of the of their experience with the CMAP system at the start of intervention and after using the CMAP system in the outpatient and community-based settings. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.

Time frame:
Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)
Reported as:
Mean · score on a scale
Change in Usability as Measured by User Experience Questionnaire (UEQ)
score on a scaleAim 3 Veterans (In-Home CMAP App)
Baseline UEQ Attractiveness1.4667 ± 0.2173
End of Aim 3 UEQ Attractiveness2.2778 ± 0.4172
Baseline UEQ Perspicuity2.3 ± 0.7374
End of Aim 3 UEQ Perspicuity2.8333 ± 0.1291
Baseline UEQ Efficiency2.1167 ± 0.1624
End of Aim 3 UEQ Efficiency2.25 ± 0.5
Baseline UEQ Dependability1.65 ± 0.3791
End of Aim 3 UEQ Dependability2.1667 ± 0.5845
Baseline UEQ Stimulation1.65 ± 0.3791
End of Aim 3 UEQ Stimulation2.5417 ± 0.4852
Baseline UEQ Novelty2.0 ± 0.5863
End of Aim 3 UEQ Novelty2.4167 ± 0.5627
Statistical analysis
  • Aim 3 Veterans (In-Home CMAP App) · Wald test for medians · p = 0.0016
  • Aim 3 Veterans (In-Home CMAP App) · Wald test for medians · p = 0.1909
  • Aim 3 Veterans (In-Home CMAP App) · Wald test for medians · p = 0.2353
  • Aim 3 Veterans (In-Home CMAP App) · Wald test for medians · p = 0.1265
  • Aim 3 Veterans (In-Home CMAP App) · Wald test for medians · p = 0.5089
  • Aim 3 Veterans (In-Home CMAP App) · Wald test for medians · p = 0.3465
PrimaryChange in Usability as Measured by System Usability Scale (SUS)

The System Usability Scale (SUS) is a 10-item Likert scale (5-item ranging from strongly disagree to strongly agree) which will allow the participants (clinicians) to give their subjective assessment of the educational formats in the CMAP system after using it for Veterans' in the outpatient and community-based settings. Total scale 0-100, where higher scores are considered highly favorable. Analysis will use Linear Mixed Effects Regression Model.

Time frame:
Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)
Reported as:
Mean · score on a scale
Change in Usability as Measured by System Usability Scale (SUS)
score on a scaleAim 3 Clinicians (In-Home CMAP App)
Aim 3 Baseline66.25 ± 47.5
End of Aim 3 Activities47.5 ± 17.6777
PrimaryChange in Usability as Measured by User Experience Questionnaire (UEQ)

The User Experience Questionnaire (UEQ) is a 26 -item semantic differential arranged on six scales (attractiveness, perspicuity, efficiency, dependability, stimulation, and, novelty) which will measure the participants' (clinicians) impression of the of their experience with the CMAP educational formats at the start of intervention and after using the CMAP system in the outpatient and community-based settings. Total scale range 1 - 7, where lower numbers indicate agreement. Analysis will use Linear Mixed Effects Regression Model.

Time frame:
Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)
Reported as:
Mean · score on a scale
Change in Usability as Measured by User Experience Questionnaire (UEQ)
score on a scaleAim 3 Clinicians (In-Home CMAP App)
Baseline UEQ Attractiveness1.1667 ± 0
End of Aim 3 UEQ Attractiveness0.7500 ± 0.5893
Baseline UEQ Perspicuity0.875 ± 0.1768
End of Aim 3 UEQ Perspicuity0.625 ± 0.8839
Baseline UEQ Efficiency0.875 ± 0.1768
End of Aim 3 UEQ Efficiency0.625 ± 0.5303
Baseline UEQ Dependability0.375 ± 0.8839
End of Aim 3 UEQ Dependability0 ± 0.7071
Baseline UEQ Stimulation1.75 ± 1.0607
End of Aim 3 UEQ Stimulation2.25 ± 0
Baseline UEQ Novelty1.75 ± 0.3536
End of Aim 3 UEQ Novelty2.0 ± 0
SecondaryPressure Ulcer Knowledge Test

The Pressure Ulcer Knowledge Test is a 9-item multiple choice survey intended to assess individuals' knowledge of pressure injury prevention activities and treatments. Total score is reported, with range 9-27. Higher scores indicate better understanding of pressure injury prevention practices.

Time frame:
Change from Aim 2 baseline (time of enrollment) to end of Aim 2 intervention (10 days following enrollment)
Reported as:
Mean · score on a scale
Pressure Ulcer Knowledge Test
score on a scaleAim 2 Veterans (In-Hospital CMAP App)
Aim 2 Baseline14.8 ± 1.9235
End of Aim 2 Intervention15.0 ± 2.0
Statistical analysis
  • Aim 2 Veterans (In-Hospital CMAP App) · Wald test for medians · p = 0.6752
SecondaryTherapist Self-Efficacy for Weight Shifts to Prevent Pressure Injuries

This self-efficacy measures clinician confidence in delivering pressure injury prevention education, specifically around instruction of how to perform weight shifts using the CMAP system during Veterans' acute rehabilitation. Total scores are reported, with range 4-40. Higher scores indicate better self-efficacy.

Time frame:
Change from Aim 2 baseline (time of enrollment) to end of Aim 2 intervention (10 days following enrollment for each Veteran case)
Reported as:
Mean · score on a scale
Therapist Self-Efficacy for Weight Shifts to Prevent Pressure Injuries
score on a scaleAim 2 Clinicians (In-Hospital CMAP App)
Aim 2 Baseline29.6 ± 8.9051
End of Aim 2 Intervention35.6 ± 5.3198
Statistical analysis
  • Aim 2 Clinicians (In-Hospital CMAP App) · Wald test for medians · p = 0.0479
SecondaryPressure Ulcer Knowledge Test

The Pressure Ulcer Knowledge Test is a 9-item multiple choice survey intended to assess individuals' knowledge of pressure injury prevention activities and treatments. Total score is reported, with range 9-27. Higher scores indicate better understanding of pressure injury prevention practices.

Time frame:
Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)
Reported as:
Mean · score on a scale
Pressure Ulcer Knowledge Test
score on a scaleAim 3 Veterans (In-Home CMAP App)
Aim 3 Baseline16.3333 ± 0.8165
End of Aim 3 Participation15.5833 ± 1.0206
Statistical analysis
  • Aim 3 Veterans (In-Home CMAP App) · Wald test for medians · p = 1.00
SecondaryTherapist Self-Efficacy for Weight Shifts to Prevent Pressure Injuries

This self-efficacy measures clinician confidence in delivering pressure injury prevention education, specifically around instruction of how to perform weight shifts using the CMAP system during Veterans' acute rehabilitation. Total scores are reported, with range 4-40. Higher scores indicate better self-efficacy.

Time frame:
Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)
Reported as:
Mean · score on a scale
Therapist Self-Efficacy for Weight Shifts to Prevent Pressure Injuries
score on a scaleAim 3 Clinicians (In-Home CMAP App)
Aim 3 Baseline30.5 ± 2.8284
End of Aim 3 Activities32.0 ± 4.9497

Adverse events

Collected over From enrollment to study completion, up to 4 years. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Aim 1 Veteran Focus Group 10/7 (0%)0/7 (0%)0/7 (0%)
Aim 1 Clinician Focus Group 10/6 (0%)0/6 (0%)0/6 (0%)
Aim 1 Veteran Focus Group 30/7 (0%)0/7 (0%)0/7 (0%)
Aim 1 Clinician Focus Group 30/5 (0%)0/5 (0%)0/5 (0%)
Aim 2 Veterans (In-Hospital CMAP App)0/5 (0%)0/5 (0%)0/5 (0%)
Aim 2 Clinicians (In-Hospital CMAP App)0/5 (0%)0/5 (0%)0/5 (0%)
Aim 3 Veterans (In-Home CMAP App)0/6 (0%)0/6 (0%)0/6 (0%)
Aim 3 Clinicians (In-Home CMAP App)0/2 (0%)0/2 (0%)0/2 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Aim 1 Veteran Focus Group 1Aim 1 Clinician Focus Group 1Aim 1 Veteran Focus Group 3Aim 1 Clinician Focus Group 3Aim 2 Veterans (In-Hospital CMAP App)Aim 2 Clinicians (In-Hospital CMAP App)Aim 3 Veterans (In-Home CMAP App)Aim 3 Clinicians (In-Home CMAP App)Total
Mean54.3 ± 11.46735 ± 8.3754.3 ± 11.46733.7 ± 7.2352.33 ± 19.9133.7 ± 2.5153.57 ± 17.7532.5 ± 2.1243.57 ± 10.82
Sex: Female, Male
Sex: Female, Male(Participants)Aim 1 Veteran Focus Group 1Aim 1 Clinician Focus Group 1Aim 1 Veteran Focus Group 3Aim 1 Clinician Focus Group 3Aim 2 Veterans (In-Hospital CMAP App)Aim 2 Clinicians (In-Hospital CMAP App)Aim 3 Veterans (In-Home CMAP App)Aim 3 Clinicians (In-Home CMAP App)Total
Female1414030114
Male6261526129
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Aim 1 Veteran Focus Group 1Aim 1 Clinician Focus Group 1Aim 1 Veteran Focus Group 3Aim 1 Clinician Focus Group 3Aim 2 Veterans (In-Hospital CMAP App)Aim 2 Clinicians (In-Hospital CMAP App)Aim 3 Veterans (In-Home CMAP App)Aim 3 Clinicians (In-Home CMAP App)Total
American Indian or Alaska Native000000000
Asian000000000
Native Hawaiian or Other Pacific Islander000000000
Black or African American000000000
White7675556243
More than one race000000000
Unknown or Not Reported000000000
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Aim 1 Veteran Focus Group 1Aim 1 Clinician Focus Group 1Aim 1 Veteran Focus Group 3Aim 1 Clinician Focus Group 3Aim 2 Veterans (In-Hospital CMAP App)Aim 2 Clinicians (In-Hospital CMAP App)Aim 3 Veterans (In-Home CMAP App)Aim 3 Clinicians (In-Home CMAP App)Total
Hispanic or Latino000000000
Not Hispanic or Latino7675556243
Unknown or Not Reported000000000
08

Study locations

1 site
  • Minneapolis VA Health Care System, Minneapolis, MN
    Minneapolis, Minnesota 55417-2309, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — De-identified data will be shared upon request, per VA requirements.

Supporting information: Study protocol, Informed consent form

Time frame: At the completion of the study.

Access criteria: Upon request once the study data analysis are completed and published.

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2020 to primary completion in Jul 2025, 61 months.

Results were first posted in Oct 2026, 1 year 2 months after primary completion.

Of 181 non-industry interventional studies with no phase under Pressure Ulcer, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's 61 months is above that.

Counting every sponsor, half of 210 studies reached it within 11 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 13, 2020
First posted
Mar 16, 2020
StartActual
Jun 1, 2020
Primary completionActual
Jul 31, 2025
CompletionActual
Jul 31, 2025
Results first posted
Oct 9, 2026
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 9, 2026
Enrollment
26→43
Oct 9, 2026
Interventions
Arms added: Aim 1 Veteran Focus Group 1·Aim 1 Clinician Focus Group 1·Aim 2 Veterans·Aim 3 Veterans·Aim 2 Clinicians·and 3 more
All 8

Aim 1 Veteran Focus Group 1 · Aim 1 Clinician Focus Group 1 · Aim 2 Veterans · Aim 3 Veterans · Aim 2 Clinicians · Aim 3 Clinicians · Aim 1 Clinician Focus Group 3 · Aim 1 Veteran Focus Group 3

; arms removed: Focus group-Veteran·Focus group-Clinicians·Usability-inpatients·Usability-in-home
Oct 9, 2026
Primary outcomes
12 edited
What changed in the outcomes
  • EditedChange in Usability as measuredMeasured by System Usability Scale (SUS)Time frame: Year 1-2: Change from baseline to second and third focus group → Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
  • EditedUsability as measuredMeasured by User Experience QuestionaireQuestionnaire (UEQ)Time frame: Year 1-2: Change from baseline to second and third focus group → Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
  • EditedChange in Usability as measuredMeasured by System Usability Scale (SUS)Time frame: Year 1-2: Change from baseline to second and third focus group → Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
  • EditedChange in Usability as measuredMeasured by User Experience QuestionaireQuestionnaire (UEQ)Time frame: Year 1-2: Change from baseline to second and third focus group → Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
  • EditedChange in Usability as measuredMeasured by System Usability Scale (SUS)Time frame: Year 2-3: compare final focus group score to after using in rehabilitation → Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment)
  • EditedChange in Usability as measuredMeasured by User Experience QuestionaireQuestionnaire (UEQ)Time frame: Year 2-3: compare final focus group score to after using in rehabilitation → Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment)
  • EditedChange in Usability as measuredMeasured by System Usability Scale (SUS)Time frame: Year 2-3: compare final focus group score to after using in rehabilitation → Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment for each Veteran case)
  • EditedChange in Usability as measuredMeasured by User Experience QuestionaireQuestionnaire (UEQ)Time frame: Year 2-3: compare final focus group score to after using in rehabilitation → Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment for each Veteran case)
  • EditedChange in Usability as measuredMeasured by System Usability Scale (SUS)Time frame: Year 4: compare initial and final use in the out patient and home setting → Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)
  • EditedChange in Usability as measuredMeasured by User Experience QuestionaireQuestionnaire (UEQ)Time frame: Year 4: compare initial and final use in the home setting → Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)
  • EditedChange in Usability as measuredMeasured by System Usability Scale (SUS)Time frame: Year 4: compare initial and final use in the home setting → Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)
  • EditedChange in Usability as measuredMeasured by User Experience QuestionaireQuestionnaire (UEQ)Time frame: Year 4: compare initial and final use in the home setting → Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)
Oct 9, 2026
Secondary outcomes
4 added, 5 removed
What changed in the outcomes
  • AddedPressure Ulcer Knowledge TestTime frame: Change from Aim 2 baseline (time of enrollment) to end of Aim 2 intervention (10 days following enrollment)
  • AddedTherapist Self-Efficacy for Weight Shifts to Prevent Pressure InjuriesTime frame: Change from Aim 2 baseline (time of enrollment) to end of Aim 2 intervention (10 days following enrollment for each Veteran case)
  • AddedPressure Ulcer Knowledge TestTime frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)
  • AddedTherapist Self-Efficacy for Weight Shifts to Prevent Pressure InjuriesTime frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)
  • RemovedChange in Self-Efficacy as measured by Skin Care Belief ScaleTime frame: Year 2-3: Pre post use of the CMAP system
  • RemovedChange in Self-Efficacy as measured by customized scaleTime frame: Year 2-3: Pre post use of the CMAP system
  • RemovedChange in Self-Efficacy as measured by Skin Care Belief ScaleTime frame: Year 4: Pre post use of the CMAP system
  • RemovedChange in Self-Efficacy as measured by customized scaleTime frame: Year 4: Pre post use of the CMAP system
  • RemovedWeight Shift bout comparisonsTime frame: Year 4
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    Results posted
    Enrollment 26→43
    Primary outcomes 12 edited
    What changed in the outcomes
    • EditedChange in Usability as measuredMeasured by System Usability Scale (SUS)Time frame: Year 1-2: Change from baseline to second and third focus group → Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
    • EditedUsability as measuredMeasured by User Experience QuestionaireQuestionnaire (UEQ)Time frame: Year 1-2: Change from baseline to second and third focus group → Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
    • EditedChange in Usability as measuredMeasured by System Usability Scale (SUS)Time frame: Year 1-2: Change from baseline to second and third focus group → Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
    • EditedChange in Usability as measuredMeasured by User Experience QuestionaireQuestionnaire (UEQ)Time frame: Year 1-2: Change from baseline to second and third focus group → Change from Focus Group 1 (at time of enrollment) to Focus Group 3 (at time of enrollment, 2 years after Focus Group 1)
    • EditedChange in Usability as measuredMeasured by System Usability Scale (SUS)Time frame: Year 2-3: compare final focus group score to after using in rehabilitation → Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment)
    • EditedChange in Usability as measuredMeasured by User Experience QuestionaireQuestionnaire (UEQ)Time frame: Year 2-3: compare final focus group score to after using in rehabilitation → Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment)
    • EditedChange in Usability as measuredMeasured by System Usability Scale (SUS)Time frame: Year 2-3: compare final focus group score to after using in rehabilitation → Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment for each Veteran case)
    • EditedChange in Usability as measuredMeasured by User Experience QuestionaireQuestionnaire (UEQ)Time frame: Year 2-3: compare final focus group score to after using in rehabilitation → Change from Aim 1 Focus Group 3 (at time of enrollment) to end of Aim 2 intervention (10 days following Aim 2 enrollment for each Veteran case)
    • EditedChange in Usability as measuredMeasured by System Usability Scale (SUS)Time frame: Year 4: compare initial and final use in the out patient and home setting → Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)
    • EditedChange in Usability as measuredMeasured by User Experience QuestionaireQuestionnaire (UEQ)Time frame: Year 4: compare initial and final use in the home setting → Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)
    • EditedChange in Usability as measuredMeasured by System Usability Scale (SUS)Time frame: Year 4: compare initial and final use in the home setting → Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)
    • EditedChange in Usability as measuredMeasured by User Experience QuestionaireQuestionnaire (UEQ)Time frame: Year 4: compare initial and final use in the home setting → Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)
    Secondary outcomes 4 added, 5 removed
    What changed in the outcomes
    • AddedPressure Ulcer Knowledge TestTime frame: Change from Aim 2 baseline (time of enrollment) to end of Aim 2 intervention (10 days following enrollment)
    • AddedTherapist Self-Efficacy for Weight Shifts to Prevent Pressure InjuriesTime frame: Change from Aim 2 baseline (time of enrollment) to end of Aim 2 intervention (10 days following enrollment for each Veteran case)
    • AddedPressure Ulcer Knowledge TestTime frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 participation (3 weeks following enrollment)
    • AddedTherapist Self-Efficacy for Weight Shifts to Prevent Pressure InjuriesTime frame: Change from Aim 3 baseline (time of enrollment) to end of Aim 3 activities (about 10 months following enrollment)
    • RemovedChange in Self-Efficacy as measured by Skin Care Belief ScaleTime frame: Year 2-3: Pre post use of the CMAP system
    • RemovedChange in Self-Efficacy as measured by customized scaleTime frame: Year 2-3: Pre post use of the CMAP system
    • RemovedChange in Self-Efficacy as measured by Skin Care Belief ScaleTime frame: Year 4: Pre post use of the CMAP system
    • RemovedChange in Self-Efficacy as measured by customized scaleTime frame: Year 4: Pre post use of the CMAP system
    • RemovedWeight Shift bout comparisonsTime frame: Year 4
    Interventions Arms added: Aim 1 Veteran Focus Group 1·Aim 1 Clinician Focus Group 1·Aim 2 Veterans·Aim 3 Veterans·Aim 2 Clinicians·and 3 more
    All 8

    Aim 1 Veteran Focus Group 1 · Aim 1 Clinician Focus Group 1 · Aim 2 Veterans · Aim 3 Veterans · Aim 2 Clinicians · Aim 3 Clinicians · Aim 1 Clinician Focus Group 3 · Aim 1 Veteran Focus Group 3

    ; arms removed: Focus group-Veteran·Focus group-Clinicians·Usability-inpatients·Usability-in-home
    + 2 other changes: index terms and verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT04309864
Responsible party
Sponsor
First posted
Mar 16, 2020
Start date
Jun 1, 2020
Primary completion
Jul 31, 2025
Completion
Jul 31, 2025
Results posted
Oct 9, 2026
Last update
Oct 9, 2026

Study contacts

Byron W Eddy
principal investigator · Minneapolis VA Health Care System, Minneapolis, MN
Christine M. Olney, BSN MS PhD
principal investigator · Minneapolis VA Health Care System, Minneapolis, MN

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion